Identification of genes down-regulated during lung cancer progression: A cDNA array study

References

Page 1

	Year	Citations
Relation of neovascularisation to metastasis of non-small-cell lung cancer Paolo Macchiarini, Gabriella Fontanini, F Squartini, The Lancet Non-small-cell Lung CancerMedicineNeovascularizationLung CancerOncology	1992	771
Expression of Wnt-5a Is Correlated with Aggressiveness of Gastric Cancer by Stimulating Cell Migration and Invasion Manabu Kurayoshi, Naohide Oue, Hideki Yamamoto, Cancer Research	2006	458
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Vincenzo Esposito, Alfonso Baldi, Antonio De Luca, PubMed Tumor BiologyP27 Protein ExpressionPrognostic RoleP27 DegradationMedicine	1997	421
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence David H. Harpole, James E. Herndon, W. Glenn Young, Cancer Surgical OncologyCancer ManagementPathologyWedge ResectionCancer Death	1995	325
Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. Ronald Feld, Larry Rubinstein, T H Weisenberger Journal of Clinical Oncology Surgical OncologyPathologyFirst RelapseOncologyVaccine Trial	1984	318
A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers Thomas A. D’Amico, Marga F. Massey, James E. Herndon, Journal of Thoracic and Cardiovascular Surgery Tumor BiologyOncologyAdvanced Lung DiseaseMedicineMultiple Pulmonary Nodule	1999	233
Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Marzieh Jönsson, Janna Dejmek, Pär‐Ola Bendahl, PubMed Breast OncologyPathologyCancer BiologyTumor BiologyCancer Cell Biology	2002	212
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer Tommaso Claudio Mineo, Vincenzo Ambrogi, Alfonso Baldi, Journal of Clinical Pathology	2004	199
Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF <sub>165</sub> antagonizes this effect Emely Castro‐Rivera, Sophia Ran, Philip E. Thorpe, Proceedings of the National Academy of Sciences	2004	181
ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines. David A. Weaver, Erin L. Crawford, Kristy A. Warner, Molecular Cancer	2005	171

Page 1